News
NICE recommends wider use of Biogen MS drug via NHS
NICE has backed NHS use of natalizumab, a key treatment option that is safe for use in pregnancy, for more patients with multiple sclerosis.
News
China delivers a win for Novo Nordisk on semaglutide IP
Novo Nordisk has been handed a crucial legal win by China's Supreme Court, which backed the validity of its patent on GLP-1 agonist semaglutide.
News
FDA declines to approve Corcept's rare disorder drug
As the celebrations for the end of 2025 gathered pace, the FDA delivered a year-end blow to Corcept by turning down its new Cushing's drug.
News
Vanda ends 40-year hiatus for new motion sickness drugs
The FDA has delivered some end-of-year cheer to Vanda Pharma after approving Nereus, its drug for the prevention of motion sickness.
News
Judge blocks HHS' 340B rebate pilot at 11th hour
A federal judge in the US has granted a restraining order that will stop the 340B rebate model from launching as planned on 1st January.
News
Press Releases
Views & Analysis
Editor's Picks
Editor's Picks
